Bibliometric analysis of the use of Immunoinformatics in the production of SARS-CoV-2 vaccine prototypes
Palabras clave:
COVID-19, immunoinformatics, bibliometrics, vaccine, VOSviewer, analysis.Resumen
The COVID-19-19 pandemic's global impact has accelerated the need for effective vaccines, challenging traditional, time-consuming, and costly vaccinology methods. Immunoinformatics emerges as a promising alternative to expedite vaccine development, thus this study aims to provide a comprehensive bibliometric analysis of its application in formulating SARS-CoV-2 vaccine prototypes. Employing VOSviewer software and data from the Web of Science database, this study conducted a bibliometric analysis. Key metrics included the global distribution of scientific publications, the most productive countries and institutions, influential authors, co-citation and co-authorship networks, and prevalent keywords in immunoinformatics research related to SARS-CoV-2 vaccines. The analysis encompassed 138 scholarly articles, with India emerging as a pivotal contributor, particularly through notable contributions from Adamas and Fakir Mohan universities. The most cited article, authored by Bhattacharya, received 226 citations, while Doytchinova was a prominent cited source, referenced in 96 of the 138 analyzed documents. The study observed substantial collaborative efforts among authors from 45 nations, with 85% of the research concentrated in just six countries. Pakistan demonstrated the highest level of international collaboration, contributing to 15/20 collaborative publications. Keywords such as 'SARS-CoV-2', 'immunoinformatics', and 'prediction' were frequently encountered across most of these documents. This bibliometric analysis elucidates the primary research trends in the field and delineates the global scope and distribution of immunoinformatics studies in the realm of SARS-CoV-2 vaccine development. These findings offer a vital overview of the current landscape, guiding future research directions and potential collaborative efforts in the pursuit of effective COVID-19 vaccines.
Citas
Masters PS. The molecular biology of coronaviruses. Advances in Virus Research. 2006;66: 193-292. DOI: https://doi.org/10.1016/S0065-3527(06)66005-3
Lauxmann MA, Santucci NE, Autrán-Gómez AM. The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak. International Braz J Urol: Official Journal of the Brazilian Society of Urology. 2020;46(1):6-18. DOI: https://doi.org/10.1590/S1677-5538.IBJU.2020.S101
Campos DMO, Oliveira CBS, Andrade JMA, Oliveira JIN. Fighting COVID-19. Brazilian Journal of Biology. 2020;80(3):986-701. DOI: https://doi.org/10.1590/1519-6984.238155
Ahmad T, Murad MA, Baig M, Hui J. Research trends in COVID-19 vaccine: a bibliometric analysis. Human Vaccines & Immunotherapeutics. 2021;17(8):2367-72. DOI: https://doi.org/10.1080/21645515.2021.1886806
da Silva MK, Fulco UL, da Silva Júnior ED, Oliveira JIN. Moving targets: COVID-19 vaccine efficacy against Omicron subvariants. Molecular Therepy. 2022;30(8):2644-5. DOI: https://doi.org/10.1002/jmv.27017 .
de Oliveira Campos DM, da Silva MK, Barbosa ED, Leow CY, Fulco UL, Oliveira JIN. Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants. Computational Biology and Chemistry. 2022;101:107754. DOI: https://doi.org/10.1016/j.compbiolchem.2022.107754
Soria-Guerra RE, Nieto-Gómez R, Govea-Alonso DO, Rosales-Mendoza S. An overview of bioinformatics tools for epitope prediction: implications on vaccine development. Journal of Biomedical Informatics. 2015;53: 405-14. DOI: https://doi.org/10.1016/j.jbi.2014.11.003
Ribeiro HCM. Bibliometrics: Fifteen Years of Analysis of Academic Production in Brazilian Journals. Biblios. 2018;0(69):1-20. DOI: https://doi.org/10.5195/biblios.2017.393
Xu Z, Qu H, Ren Y, Gong Z, Ri HJ, Zhang F, et al. Update on the COVID-19 Vaccine Research Trends: A Bibliometric Analysis. Infection and Drug Resistance. 2021;14:4237-47. DOI: https://doi.org/10.2147/IDR.S335745
Suela SC, Moreto ER, Freitas RR de. Bibliometria e seus Métodos de Pesquisa: Um Estudo nas Bases de Dados Scopus e Web of Science/Bibliometric and its Research Methods: A Scopus and Web of Science Database Study. Revista FSA (Centro Universitário Santo Agostinho). 2021;18(6):151-68. DOI: https://doi.org/10.12819/2021.18.6.8
Wei WT, Wei CK, Wu CC. Trends in Research about COVID-19 Vaccine Documented through Bibliometric and Visualization Analysis. Healthcare (Basel, Switzerland). 2022;10(10):1942. DOI: https://doi.org/10.3390/healthcare10101942
Huggett S. The bibliometrics of the developing world- Research Trends. [accessed 02/02/2023]. Available at: https://www.researchtrends.com/exhibit/research-trends/the-bibliometrics-of-the-developing-world/
Akintunde TY, Chen S, Musa TH, Amoo FO, Adedeji A, Ibrahim E, et al. Tracking the progress in COVID-19 and vaccine safety research-a comprehensive bibliometric analysis of publications indexed in Scopus database. Human Vaccines & Immunotherapeutics. 2021;17(11):3887-97. DOI: https://doi.org/10.1080/21645515.2021.1969851
Chen Y, Cheng L, Lian R, Song Z, Tian J. COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer. Bioscience Trends. 2021;15(2): 64-73. DOI: https://doi.org/10.5582/bst.2021.01061
Bhattacharya M, Sharma AR, Patra P, Ghosh P, Sharma G, Patra BC, et al. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. Journal of Medical Virology. 2020;92(6):618-31. DOI: https://doi.org/10.1002/jmv.25736
Enayatkhani M, Hasaniazad M, Faezi S, Gouklani H, Davoodian P, Ahmadi N, et al. Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in-silico study. Journal of Biomolecular Structure & Dynamics. 2021;39(8):2857-72. DOI: https://doi.org/10.1080/07391102.2020.1756411
Panda PK, Arul MN, Patel P, Verma SK, Luo W, Rubahn HG, et al. Structure-based drug designing and immunoinformatics approach for SARS-CoV-2. Science Advances. 2020;6(28):eabb8097. DOI: https://doi.org/10.1126/sciadv.abb8097
Abdelmageed MI, Abdelmoneim AH, Mustafa MI, Elfadol NM, Murshed NS, Shantier SW, et al. Design of a Multiepitope-Based Peptide Vaccine against the E Protein of Human COVID-19: An Immunoinformatics Approach. BioMed Research International. 2020;2020:2683286. DOI: https://doi.org/10.1155/2020/2683286.
Dong R, Chu Z, Yu F, Zha Y. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches. Frontiers in Immunology. 2020;11. DOI: https://www.frontiersin.org/articles/10.3389/fimmu.2020.01784
Samad A, Ahammad F, Nain Z, Alam R, Imon RR, Hasan M, et al. Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach. Journal of Biomolecular Structure & Dynamics. 2022;40(1):14-30. DOI: https://doi.org/10.1080/07391102.2020.1792347
Yang Z, Bogdan P, Nazarian S. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study. Scientific Reports. 2021;11(1):32-8. DOI: https://doi.org/10.1038/s41598-021-81749-9
Tahir Ul Qamar M, Rehman A, Tusleem K, Ashfaq UA, Qasim M, Zhu X, et al. Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches. PloS One. 2020;15(12):e0244176. DOI: https://doi.org/10.1371/journal.pone.0244176
Tahir Ul Qamar M, Shahid F, Aslam S, Ashfaq UA, Aslam S, Fatima I, et al. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2. Infectious Diseases of Poverty. 2020;9(1):132. DOI: https://doi.org/10.1186/s40249-020-00752-w
Bhattacharya M, Sharma AR, Mallick B, Sharma G, Lee SS, Chakraborty C. Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex. Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. 2020;85:104587. DOI: https://doi.org/10.1016/j.meegid.2020.104587
Rashid A, Li K, Feng Y, Ahmad T, Getaneh Y, Yu Y, et al. HIV-1 genetic diversity a challenge for AIDS vaccine development: a retrospective bibliometric analysis. Human Vaccines & Immunotherapeutics. 2022;18(1):2014733. DOI: https://doi.org/10.1080/21645515.2021.2014733
Oyewola DO, Dada EG. Exploring machine learning: a scientometrics approach using bibliometrix and VOSviewer. SN Applied Sciences. 2022;4(5):143. DOI: https://doi.org/10.1007/s42452-022-05027-7
Miguéis A, Neves B, Silva AL, Trindade Á, Bernardes JA. A importância das palavras-chave dos artigos científicos da área das Ciências Farmacêuticas, depositados no Estudo Geral: estudo comparativo com os termos atribuídos na MEDLINE. InCID: Revista de Ciência da Informação e Documentação. 2013;4(2):112-25. DOI: https://doi.org/10.11606/issn.2178-2075.v4i2p112-125
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Aquellos autores que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0) que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un repositorio institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores difundir su obra a través de Internet (p. ej.: en repositorios institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto). En ese caso, solicitamos que en la cabecera del manuscrito se indique:"Esta es una versión preprint enviada a la Revista Cubana de Información en Ciencias de la Salud http://rcics.sld.cu/"
ENGLISH VERSION
AUTHORS WITH PUBLICATIONS IN THIS JOURNAL ACCEPT THE FOLLOWING TERMS:
- Authors will retain their copyright and will grant the Journal the right of first publication of their work, which will also be subject to a Creative Commons License Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) allowing third parties to share the work as long as the author's name and data about initial publication in this Journal are stated.
- Authors may adopt other license agreements for non-exclusive distribution of the version of the work published (e.g. deposit it in an institutional repository or publish it in a monographic volume), as long as initial publication in this Journal is indicated.
- It is permitted and recommended for authors to disseminate their work on the Internet (e.g. in institutional repositories or their web page) before and during the submission process, which may result in interesting exchanges and increase the number of citations of the published work) (see The effect of open access).
